Clorox (NYSE:CLX) Price Target Cut to $95.00 by Analysts at BNP Paribas Exane

Clorox (NYSE:CLX) had its price objective dropped by analysts at BNP Paribas Exane from $97.00 to $95.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. BNP Paribas Exane’s price objective indicates a potential downside of 0.65% from the company’s previous close.

Several other equities analysts also recently weighed in on CLX. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. Citigroup reduced their price target on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. Royal Bank Of Canada lowered their price target on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. Jefferies Financial Group dropped their price objective on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Finally, TD Cowen lifted their price objective on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $103.33.

Clorox Price Performance

Clorox stock traded down $0.69 during trading hours on Monday, hitting $95.62. The stock had a trading volume of 903,246 shares, compared to its average volume of 2,541,578. Clorox has a 1-year low of $84.70 and a 1-year high of $132.03. The stock has a market capitalization of $11.56 billion, a price-to-earnings ratio of 15.53 and a beta of 0.54. The stock’s fifty day moving average is $94.59 and its two-hundred day moving average is $104.04. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the company posted $1.45 EPS. The business’s revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, analysts predict that Clorox will post 5.52 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Pierre R. Breber bought 5,000 shares of Clorox stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.63% of the company’s stock.

Institutional Investors Weigh In On Clorox

A number of hedge funds and other institutional investors have recently modified their holdings of CLX. Wilkins Investment Counsel Inc. grew its holdings in Clorox by 250.6% in the 4th quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after buying an additional 39,360 shares in the last quarter. Morningstar Investment Management LLC boosted its position in Clorox by 131.8% during the 4th quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock worth $6,297,000 after acquiring an additional 35,506 shares during the period. National Pension Service increased its holdings in shares of Clorox by 68.9% during the fourth quarter. National Pension Service now owns 27,537 shares of the company’s stock valued at $2,777,000 after purchasing an additional 11,233 shares during the period. Birch Hill Investment Advisors LLC bought a new stake in shares of Clorox during the fourth quarter valued at about $22,103,000. Finally, Ilmarinen Mutual Pension Insurance Co acquired a new stake in Clorox in the fourth quarter worth about $1,966,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.